Cerus Corp

CERSNASDAQUSD
1.98 USD
0.08 (4.21%)AT CLOSE (11:59 AM EDT)
2.01
0.03 (1.52%)
POST MARKET (AS OF 06:50 PM EDT)
Post Market
AS OF 06:50 PM EDT
2.01
0.03 (1.52%)
🔴Market: CLOSED
Open?$1.88
High?$1.98
Low?$1.88
Prev. Close?$1.90
Volume?1.1M
Avg. Volume?1.5M
VWAP?$1.94
Rel. Volume?0.78x
Bid / Ask
Bid?$1.63 × 100
Ask?$2.30 × 100
Spread?$0.67
Midpoint?$1.96
Valuation & Ratios
Market Cap?396.7M
Shares Out?200.4M
Float?178.5M
Float %?92.9%
P/E Ratio?N/A
P/B Ratio?6.18
EPS?-$0.08
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.73Adequate
Quick Ratio?1.17Adequate
Cash Ratio?0.20Low
Debt/Equity?1.31Moderate
ValuationATTRACTIVELY VALUED
Score
80/100
P/E?
N/A
P/B?
6.18FAIR
P/S?
1.70CHEAP
P/FCF?
358.1PRICEY
EV/EBITDA?
-63.5CHEAP
EV/Sales?
1.97CHEAP
Returns & Efficiency
ROE?
-24.3%WEAK
ROA?
-7.0%WEAK
Cash Flow & Enterprise
FCF?$1.1M
Enterprise Value?$460.7M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Employees
345
Market Cap
396.7M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
1997-01-31
Address
1220 CONCORD AVENUE
CONCORD, CA 94520
Phone: (925) 288-6000